New Deal

Announced

2 Nov 2015

Completed

22 Jan 2016

DYAX CORP. / SHIRE PLC / Acquisition / Public / £3838m

Financials

Edit Data

Transaction Value£3,838m

Consideration TypeCash, Contingent Deferred Consideration

Capital Owned-

Capital Bid For100%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

Dyax Corp.

bidder

Shire

Sources

Edit

Tags

Edit

biopharmaceuticals

Pharmaceuticals

United States

Public

Acquisition

Completed

Friendly

Synopsis

Edit

Acquisition by Shire of Dyax Corp, a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products.

Service Providers (9)

Dealmakers

financial advisors

Centerview Partners

legal advisors

Sullivan & Cromwell

legal advisors

Latham & Watkins

financial advisors

Deutsche Bank

financial advisors

Evercore

financial advisors

Morgan Stanley

legal advisors

Ropes & Gray

legal advisors

Davis Polk & Wardwell

legal advisors

Slaughter & May

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.